Universitätsklinikum Heidelberg

Improvements in Walking Distance during Nusinersen Treatment - A Prospective 3-year SMArtCARE Registry Study (2023) Pechmann A, Behrens M, Dörnbrack K, Tassoni A, Wenzel F, Stein S, Vogt S, et al. Journal article Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4 (2023) Kayser S, Martínez-Cuadrón D, Hanoun M, Stölzel F, Gil C, Reinhardt HC, Aguiar E, et al. Journal article Das große Verbesserungspotenzial in der multimodalen Basisbehandlung der peripheren arteriellen Verschlusskrankheit (pAVK): ein Aufruf zum flächendeckenden Ausbau der pAVK-Gehtrainingsgruppen in Deutschland (2023) Dovzhanskiy D, Behrendt CA, Görtz H, Uhl C, Classen S, Marchiori E, Neufang A, et al. Journal article Chronische Entzündungserkrankungen in Deutschland: Eine Querschnittanalyse über Begleiterkrankungen und Arzneimitteleinsatz (2023) Leipe J, Schmelz R, Riemekasten G, Thaçi D, Henes J, Schäkel K, Pinter A, et al. Journal article Guidelines for mouse and human DC functional assays (2022) Clausen BE, Amon L, Backer RA, Berod L, Bopp T, Brand A, Burgdorf S, et al. Journal article Diagnosis and treatment of adult-onset Still's disease: a concise summary of the German society of rheumatology S2 guideline (2022) Vordenbaeumen S, Feist E, Rech J, Fleck M, Blank N, Haas JP, Koetter I, et al. Journal article Immune checkpoint inhibition and targeted therapy for melanoma: A patient-oriented cross-sectional comparative multicentre study (2022) Thiem A, Mashhadiakbar P, Cussigh C, Hassel JC, Grimmelmann I, Gutzmer R, Schlaak M, et al. Journal article Expanding the molecular spectrum of gene fusions in endometrial stromal sarcoma: Novel subunits of the chromatin remodeling complexes PRC2 and NuA4/TIP60 as alternative fusion partners (2022) Dermawan JKK, Dashti N, Chiang S, Turashvili G, Dickson BCC, Ellenson LHH, Kirchner M, et al. Journal article CAD-RADS Scoring using Deep Learning and Task-Specific Centerline Labeling (2022) Denzinger F, Wels M, Taubmann O, Gülsün MA, Schöbinger M, Andre F, Buss SJ, et al. Conference contribution, Conference Contribution Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial (2022) Zeyen T, Potthoff AL, Nemeth R, Heiland DH, Burger MC, Steinbach JP, Hau P, et al. Journal article